tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Navin Jacob, 28 are a HOLD (43.75%), 34 are a BUY (53.13%), 2 are a SELL (3.13%).
Analyst Navin Jacob, carries an average stock price target met ratio of 74.54% that have a potential upside of 22.6% achieved within 519 days. Previously, Navin Jacob worked at UBS, DEUTSCHE BANK.
Navin Jacob’s has documented 130 price targets and ratings displayed on 19 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ABBV, AbbVie at 03-Feb-2025.
Analyst best performing recommendations are on RAPT (RAPT THERAPEUTICS).
The best stock recommendation documented was for RAPT (RAPT THERAPEUTICS) at 11/25/2019. The price target of $208 was fulfilled within 4 days with a profit of $27.76 (11.77%) receiving and performance score of 29.44.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 10-Sep-2026
$315
$52.18 (19.85%)
$265
24 days ago
(10-Sep-2026)
6/7 (85.71%)
$60 (23.53%)
115
Buy Since 12-Sep-2025
$303
$40.18 (15.29%)
$298
1 months 14 days ago
(20-Aug-2026)
2/11 (18.18%)
$41.17 (15.72%)
35
Buy Since 09-Dec-2021
$300
$37.18 (14.15%)
$295
1 months 17 days ago
(17-Aug-2026)
14/16 (87.5%)
$49.67 (19.84%)
506
Hold Since 13-Aug-2026
$300
$37.18 (14.15%)
1 months 21 days ago
(13-Aug-2026)
1/2 (50%)
$49.18 (19.61%)
115
Buy Since 23-Jan-2023
$260
$-2.82 (-1.07%)
$235
1 months 24 days ago
(10-Aug-2026)
9/9 (100%)
$12.03 (4.85%)
133
